Cargando…
Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients
In pancreatic cancer clinical trials, Black patients are under-represented while having higher morbidity and mortality rates as compared to other racial groups. Multiple factors, including socioeconomic and lifestyle factors may contribute to this disparity, but genomic contributions remain unclear....
Autores principales: | Biel, Thomas G., Petrovskaya, Svetlana, Mascia, Francesca, Ju, Tongzhong, Fashoyin-Aje, Lola, Herremans, Kelly M., Riner, Andrea N., Underwood, Patrick W., Gerber, Michael H., Donoghue, Martha, Trevino, Jose G., Rao, V. Ashutosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946261/ https://www.ncbi.nlm.nih.gov/pubmed/36812168 http://dx.doi.org/10.1371/journal.pone.0281182 |
Ejemplares similares
-
To Adjudicate or Not Adjudicate: That Is the Question
por: Hicks, Karen A., et al.
Publicado: (2022) -
FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD‐L1
por: Fashoyin‐Aje, Lola, et al.
Publicado: (2018) -
Changing Practice Patterns and Improving Survival for Patients with Pancreatic Ductal Adenocarcinoma
por: Underwood, Patrick W., et al.
Publicado: (2023) -
The Microbiota and Cancer Cachexia
por: Herremans, Kelly M., et al.
Publicado: (2019) -
Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials
por: Riner, Andrea N., et al.
Publicado: (2022)